Results 101 to 110 of about 2,882 (191)

Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation. [PDF]

Pharmaceutics, 2023
El-Dahmy RM, Elsayed I, Hussein J, Althubiti M, Almaimani RA, El-Readi MZ, El-Readi MZ, Elbaset MA, Ibrahim BMM.   +8 more
europepmc   +1 more source

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil

Vascular Health and Risk Management, 2011
R Preston MasonCardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, and Elucida Research, Beverly, MA, USAAbstract: Cardiovascular (CV) disease is a major factor in mortality rates around the world and ...
Mason
doaj  

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTENEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL AND CHLORTHALIDONE IN TABLET DOSAGE FORM [PDF]

, 2015
Objective: To develop and validate a simple, rapid, accurate and precise RP-HPLC method for the simultaneous determination of olmesartan medoxomil (OLM) and chlorthalidone (CHL) in pharmaceutical formulation.Methods: Chromatographic separation was ...
Dangre, Pankaj, Dhabarde, Disha, Sawale, Vilas   +2 more
core  

Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines

Clinical Interventions in Aging, 2015
Stefano Omboni,1 Ettore Malacco,2 Jean-Michel Mallion,3 Massimo Volpe4,5 1Clinical Research Unit, Italian Institute of Telemedicine, Solbiate Arno, Varese, Italy; 2Department of Internal Medicine, Ospedale L Sacco, University of Milan, Milan, Italy ...
Omboni S, Malacco E, Mallion JM, Volpe M
doaj  

Exploring the Effectiveness and Safety of Azilsartan-Medoxomil/Chlorthalidone Versus Olmesartan-Medoxomil/Hydrochlorothiazide in Hypertensive Patients: A Meta-Analysis. [PDF]

Cureus, 2023
Kumar L, Khuwaja S, Kumar A, Memon UA, Kumar M, Ashok A, Lohana M, Qudoos A, Kashif M, Khatri M, Kumar S, Sapna F, Dass A, Varrassi G.   +13 more
europepmc   +1 more source

Olmesartan/amlodipine: a review of its use in the management of hypertension

Vascular Health and Risk Management, 2011
R KreutzInstitute of Clinical Pharmacology and Toxicology, Charité, Universtitätsmedizin – Berlin, GermanyAbstract: Combination therapy is an effective strategy to increase antihypertensive efficacy in those patients with poor blood ...
Kreutz R
doaj  

The Efficacy of Single-pill Combination of Olmesartan Medoxomil and Amlodipine Besylate on Office Blood Pressure in Hypertensive Patients who did not Respond to Amlodipine Besylate Monotherapy. [PDF]

Electrolyte Blood Press, 2023
Kim BK.
europepmc   +1 more source

Спектрофотометрическое определение метопролола тартрата в таблетках [PDF]

, 2014
МЕТОПРОЛОЛТАРТРАТЫСПЕКТРОФОТОМЕТРИЯТАБЛЕТК
Васюк, С. А., Жук, Ю. Н.
core  

Design of Olmesartan Medoxomil-Loaded Nanosponges for Hypertension and Lung Cancer Treatments. [PDF]

Polymers (Basel), 2021
Almutairy BK, Alshetaili A, Alali AS, Ahmed MM, Anwer MK, Aboudzadeh MA.   +5 more
europepmc   +1 more source

Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study

Кардиоваскулярная терапия и профилактика, 1970
Aim. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study was a double-blind trial in patients with hypertension at increased cardiovascular risk with carotid wall thickening and a defined atherosclerotic plaque that used non ...
Kl. O. Stumpe, E. Agabiti-Rosei, T. Zielinski, D. Schremmer, J. Scholze, P. Laeis, P. Schwandt, M. Ludwig   +7 more
doaj